ORM1 anticorps (C-Term)
Aperçu rapide pour ORM1 anticorps (C-Term) (ABIN453240)
Antigène
Voir toutes ORM1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- This antibody reacts to Alpha-1-acid glycoprotein 1.
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogène
- KLH conjugated synthetic peptide selected from the C-terminal region of human ORM1
-
-
-
-
Indications d'application
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ORM1 (Orosomucoid 1 (ORM1))
-
Autre désignation
- ORM1 / AGP1
-
Sujet
- ORM1 is a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined, however, it may be involved in aspects of immunosuppression.Synonyms: Alpha-1-acid glycoprotein 1, OMD1, Orosomucoid-1
-
ID gène
- 5004
-
NCBI Accession
- NP_000598
-
UniProt
- P02763
-
Pathways
- Response to Growth Hormone Stimulus
Antigène
-